Related Experiment Video
Updated: Jul 7, 2026

3D Modeling of Dendritic Spines with Synaptic Plasticity
Published on: May 18, 2020
The role of GSK-3 in synaptic plasticity
S Peineau1, C Bradley, C Taghibiglou
1Department of Anatomy, MRC Centre for Synaptic Plasticity, School of Medical sciences, University Walk, Bristol, UK.
Abstract:
Glycogen synthase kinase-3 (GSK-3), an important component of the glycogen metabolism pathway, is highly expressed in the CNS. It has been implicated in major neurological disorders including Alzheimer's disease, schizophrenia and bipolar disorders. Despite its central role in these conditions it was not known until recently whether GSK-3 has neuronal-specific functions under normal conditions. However recent work has shown that GSK-3 is involved in the regulation of, and cross-talk between, two major forms of synaptic plasticity, N-methyl-D-aspartate receptor (NMDAR)-dependent long-term potentiation (LTP) and NMDAR-dependent long-term depression (LTD). The present article summarizes this recent work and discusses its potential relevance to the treatment of neurological disorders.
Related Concept Videos
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Role of Neurotransmitters in Memory
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is critical for...
Integration of Synaptic Events
Long-term Potentiation
Long-term Potentiation
Hebbian LTP
LTP can occur when presynaptic neurons...
Excitatory and Inhibitory Effects of Neurotransmitters